Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Mycoplasma capricolum subsp. capricolum ATCC 27343, ATCC 27343

>MCAP_0022 acyl carrier protein phosphodiesterase, putative
MSKVLVLKTTAQADEVSNSVALTNRFLEEYKKFNPDDEIIIVDLNKDEVG
TSILTSETFPTFYQQEVTKKYINLLKSVDKLVIACPMYNFSTPVTLKSFI
DHVSVANETFSYKYSKKGDAIGLITNLKAQILGVQGAPLGWYPWGQHTQY
VEGAMRFLGIEFNKTVLLAGVKVAPLLELTPAQRVETIIDEVIQAAKTF
>MCAP_0847 conserved hypothetical protein
MKTEIISTKDNKKIVLYKWDEVIRPLAVIQLVHGSCEHLKRYEDFAKEMN
QNNVIVVGIDQRGHGQTSVLNNELGYFNKTKGWECLIEDQLLVNQYIKTN
YINLPIYMLGHSMGSFVARSYAIKYSDTIKGLILSGTNQTNSFVLISALL
LTSLTSLFIKEKQPNKIIWNISYKTLNKKFKTNNANGVEWLTRDKNIQNQ
FLNDKLCGFVFSSSAFKDMFKGMLFNLKSKNLKKMNKNLRILLLTGSDDP
VSHFSKDAVKFSNKLNKLDYSYQLIIYPNFRHEILNELDKNLVIRDILKF
M
>MCAP_0647 acyl carrier protein, putative
MTIYNQIIKELKSRGAKGNLTKDSEFKSLGLDSLDLMDMVVTLEEKLDIR
ISDDQLLSLRTIDDLLKVIEELK
>MCAP_0029 oxidoreductase, short chain dehydrogenase/reductase family
MKKVAIIAGGAKSLGKFLALGLDKNNYQVIVLDVNKQKLDELKLENNQID
TFECDLTNEIDVINVFNEIENKYKTIDTLVYNAGWAKSAKITSFEYQDFI
TSLKINLDGYFLTAKQAAKIMIKNNTKGNIIQINSKSGRVGSKYNSGYSA
AKFGGVGLTQSLALDLAEHNIRVNSLMLGNLLDSEMFESLIPQYAKKLNI
KESEVKQYYIDKVPLKRGCSFDDVLNVLLFYISLKASYCTGQSINITGGQ
VM
>MCAP_0150 cardiolipin synthetase, putative
MKKPIITVLSLIFMFGLTILGLLLLNFGLFTWPLIGFGIFHLLAIIWAFI
VLADKKRRFETRIRWFCFIVVIPIIGVLSYLFFGRSYKYKINTSYKLPEI
KNKHLINELKEVEEILINQIPQFKRAFKTAMISQTNNIFLNSEVEFLKNG
NELFLNLFKDISNAKSHILLNFYIFKDGKLLEQLTNLLIKKLKENVKVYI
IYDFAGSYTVFEESRLKLLKHGCQIACFAPVRFPFIKWTANYRDHRKDVV
IDNKIGYIGGINIGDEYINLDNKFGYWNDCSLRITGNAVSEIQRIFISDY
DFYKPFNKKRLIESDLNLNTIYPVKSKNQLVQIVSSGPNHEEPLHLSIFI
NLINSAQKRIWISTPYFIPPQEIRTALINAANSKLDVRILIPGLTDKAFL
LDQTKQWTRELYKAGVKIYSINNVFNHNKTYLFDDEITFIGSTNLDFRAL
FADQQTMGLIYSKKLNNTISKKFEQDFKNSYLYDHLPNKNINWFRKIIIK
IYNIIQPLL
>MCAP_0214 PAP2 superfamily domain membrane protein
MKNKINHYYIYSGIVFIILISLFIIGSIYDFKIASFKRVENLSLAIFVSN
FGVLIPSISLTIPLIYLIKSLKFKNKLKINNVIETLIYFVIPLGFVIFNF
LYEKQSVVYSIISSLLCLIIISILIYYFHINKEIIIDSNLSIYKAIIVLT
TIIGLLILVNILKLLFNRPRPTDLELYRNWWNIKWTSWKHNSFPSGHTYS
ATTLLFVLLLFNKINKKAYLWISVTWLIIIIVAMSRIVLNKHFLTDVVLS
MLLSFTILTTILIVNHKKGKLFI
>MCAP_0402 1-acyl-sn-glycerol-3-phosphate acyltransferase, putative
MIKMNQVNSLNTEPKNTLNNIQHEKKNKDYIHVNPWKMLFMWLPLLHIKF
KAAKIVRKNKKQPDRYPEEYRYNWVKKAVSKLLYVLDVNIKVEGIENWMD
KGVILAANHQSNIDPVILFAINDFSKQQPLAFIAKEELWTSKKFKNFVRL
VDCIPLNRKSPRSALEAFKEAKDLVVDYKRSLVIFPEGTRSHSQQMNSFQ
AASLKVAQMSHAPIIPVSIINSYLVFAEKRPKKVEVKVVFGKPILPSKHI
SLKTEDLTRFVEKNVSSNLKKWENKEMKYELKKLTKKDVKQLKEEEKKQK
DKKTNKKSIKDLFKIVD
>MCAP_0320 conserved hypothetical protein
MKQIDIQTIDDHQVKTYVFDKVKKPIAVLHIISSNLNVIDFYKNFFQVLN
NNQIIVVCNSIQNSLNIRNQAKIFNDNWKINLEDLKEVNHFIKKQYKLPI
FMFSHSIACVFSKAYSIKYSETINGLILSNYLELNKKIIIKQIFKLIFIK
LFFKNKNQYSFYQDSFIQKFLNKFNQNNNLLVNKLNRYLDILEDDFISKK
FDIISLLDVYKTMYFNLKRKNLNLIKKHLPILIIVNDNNYQEEKKYLKSS
YKLLKQLLKKDYYVSLNYIDDLKNKMFTNSNLILENQIITFINKHLIHI
>MCAP_0400 holo-(acyl-carrier-protein) synthase, putative
MINNVGIDIVENKRIKLKEEFIVKVLSANEIKTFNIKNKKQKREFLAGRW
AIKEAIIKTLDQPISMNKIDIEYINDKPVIKNQELQNILISISHEKKYAV
GIALKQCDNK
>MCAP_0340 cdsA, phosphatidate cytidylyltransferase
MNTIITKDENSIKQIKKNLKTRLISATILVLLLGFYLAFPILYYFTNNSS
FHLLTAYNLISLILSSVVLFLSIRELLISFNIKNLDQKLFLEILTVVLFW
IPFSNIESKIPVYNSLNLKEYWYLIIIAIVLYLFLTTLFLMKFCNKNIIQ
VTKILFVLLIMVFAFKAINFLGFLKTNGVILYGFSSIIWIWATIILTDSF
AYLFGIRFGRHKLAPSISPKKSWEGAIGGFFLSTIINLIWVLTIFFVPWT
RNFAPFIGMFDLLLNNNVTLMLLVYVFLTILISLFTQFGDLVFSYIKRSI
DVKDFSNLIPGHGGILDRLDSFYFVFFIIYIILHISLTFNRI
>MCAP_0808 pgsA, CDP-diacylglycerol--glycerol-3-phosphate3-phosph atidyltransferase
MKQRTINLPNILTTIRIILVPIIIILLLVDHYINKTVFTNFSKFVWFFSG
AIFIIASLTDFLDGWIARKYNLVTNFGKFFDPIADKLLVNATLILFSSLG
VLPIWMTVVLILRDTFIDFIRMILSSNGITLAAGIGGKLKTTFQMIGLSL
LFFVNLKVFGWVELDWQNQLVLLPMYIAIFFSIYSGVIYFLSAKPNLF
>MCAP_0491 plsX, fatty acid/phospholipid synthesis protein PlsX
MYKIAFDVMGSDLGSLTAIKAASEFIKEHNDLYLILVGDETEIKTALEQN
PIDKNKYEILPTTQVIDMNGSILDIRRKKDASIIRTLELVRDQKVDGMLT
AGNSAAFIGAAHFILGELNNIVRAGFMPTMPNAKNKLTLLLDVGANSENT
PEDLINYAKMANIYYTEVLKNPNATVGLLNIGTEKSKGLELQKQTFKQLE
KLKNINFVGNVESRDVLTGNVDIIVTDGYSGNICLKACEGAAKVLLTEIK
KEITSSFIRKLAALVLKKSFKNVAAKFDYKNHAGAILLGVKGICFKSHGS
SDVRSFKATLRMTLDAIKNNIVEKIEKGLIKNEY